Lead Principal Investigator definition

Lead Principal Investigator means the Investigator identified in the Letter of Award as the overall lead in the conduct of the Research;
Lead Principal Investigator means, consistent with Section VI of this Agreement, the Principal Investigator designated by the other Principal Investigators pursuant to Section VI (B), who, as the lead organization, will submit the application for federal funds to the DOE under the FOA. The Lead Principal Investigator shall serve as the primary contact to the DOE.
Lead Principal Investigator means the Inv as the overall lead in the conduct of the Research;

Examples of Lead Principal Investigator in a sentence

  • Multiple Investigator applications may be submitted as: (1) a single Lead Principal Investigator (PI) application with Co-PI(s) or (2) a Multiple PI application (with a single Contact PI).

  • For multiple applications associated with the same project, the Lead Principal Investigator should include a spreadsheet that displays the total budget for all partners.

  • Applicant/ Project ConsortiumA project consortium must be consisted of at least three eligible research teams from at least three different participating countries listed above.Each research team shall be led by a Principal Investigator (PI), and a consortium shall be led by a Lead Principal Investigator (Lead PI) specified among the PIs. The Lead PI will be responsible for running and managing the project.

  • Be careful using these hosting services as they too have security issues.

  • Where its chief executive officer is also the Lead Principal Investigator, the Host Institution shall appoint another person from the governing body to which the chief executive officer reports to represent the Host Institution.

  • The Lead Principal Investigator shall inform Grantor if scientific work on the Research is unable to commence within three (3) months from the beginning of the Term.

  • The Lead Principal Investigator (PI) or Project Director should not be changed unless unavoidable and only minor edits should be made, if necessary, to the title.

  • The Lead Principal Investigator, who is the EFRC Director, and anyone submitting on behalf of the Lead Principal Investigator must register for an account in PAMS prior to submitting a pre-application.

  • Proposals that exceed the institutional eligibility limit (beyond the first two submissions based on timestamp) will be returned without review regardless of the institution's role (lead, non-lead, subawardee) in the returned proposal..Limit on Number of Proposals per PI or Co-PI: 1An individual may serve as Lead Principal Investigator (PI) or Co-PI on only one proposal submitted to the IGE program per annual competition.

  • Each optional letter of collaboration may contain two and only two sentences and must use the following format: Dear <Lead Principal Investigator Name>: If your application / proposal entitled, “<Application Name>,” is selected for funding by DOE, it is my intent to collaborate in this research by <Complete sentence with a very short description of what the collaborator offers to do or provide>.


More Definitions of Lead Principal Investigator

Lead Principal Investigator or ‘Lead PI” means the person named in the Letter of Award as Lead Principal Investigator for the Research;

Related to Lead Principal Investigator

  • Principal Investigator or “PI” is the person, designated by University, and accepted by Sponsor, who is directly responsible for executing, directing, overseeing and reporting a Sponsored Project under this Agreement.

  • Investigator means an individual who is:

  • Investigators means those persons authorised, appointed, consulted or approached by the Chairman of the Audit Committee and includes the Auditors of the Company and the Police.

  • Collaborating physician means the physician who,

  • CRO means a contract research organization.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.